Team:Debrecen-Hungary/project

From 2010.igem.org

(Difference between revisions)
m
Line 58: Line 58:
The examination of these chimeric receptors was through a version of the [http://2010.igem.org/Team:Debrecen-Hungary/minimals#Cotransfection_Assay_Two_Hybrid_Assay two hybrid assay]. For a more detailed description of our experimental system, please visit our [http://2010.igem.org/Team:Debrecen-Hungary/minimals#Cotransfection_Assay_Two_Hybrid_Assay "Minimals"] page.
The examination of these chimeric receptors was through a version of the [http://2010.igem.org/Team:Debrecen-Hungary/minimals#Cotransfection_Assay_Two_Hybrid_Assay two hybrid assay]. For a more detailed description of our experimental system, please visit our [http://2010.igem.org/Team:Debrecen-Hungary/minimals#Cotransfection_Assay_Two_Hybrid_Assay "Minimals"] page.
 +
<html><br><a name="results"></a><br></html>
='''Results'''=
='''Results'''=
Line 142: Line 143:
=''' Request for comment suggestion : ?????? '''=
=''' Request for comment suggestion : ?????? '''=
 +
 +
<html><br><a name="plans"></a><br></html>
 +
='''Plans, Possibilities'''=
='''Plans, Possibilities'''=

Revision as of 09:23, 26 October 2010




Contents

Abstract

Eukaryotic synthetic biology has huge potential, yet it is still in need of more diverse molecular tools for defined gene regulation. Nuclear receptors are a conserved family of proteins responsible for sensing lipids; they may be viewed as lipid activated transcription factors. We have successfully developed a kit with a variety of lipid responsive domains (from H.sapines, D.melanogaster and C.elegans) for the rational construction of synthetic transcription factors. The domains respond only to predefined lipids and selectively activate predetermined gene expression. To characterize theses domains, we used standardized protocols for comparable measurements. In vivo gene expression was measured as a function of ligand concentration using luciferase activity.


The potential for these tools is immense; e.g. from the ultra sensitive detection of lipid contaminants in the environment to the opportunity of titration specific gene expression canges in patients undergoing gene therapy.



Introduction

Synthetic Biology

Synthetic biology is a relatively new area of biological research; similar to many other new scientific fields it has many definitions. The best way to express the meaning of synthetic biology is to understand the desired end-result: engineering of complex biological systems. These systems are best thought of as analogues of everyday machinery: cogwheels, levers, timers, button and buzzers (in this case a clock), only in the case of biological systems (molecular ones) cells, DNA, proteins, lipids, sugars and RNA are the “parts” of the system.

Similar to mechanical engineering (or every other engineering branch) there is a need for standards (consensus way of doing things), abstraction (simple and unified way of thinking about the parts of a system), and modularity (how these parts interact to become the device, or several devices into a system). Thus a good definition for synthetic biology could be engineering of molecular (for the time being) biological systems according to preset standard parts. The international genetically engineered machines and associated parts registry are, to date, one of the largest registries for standard parts in use for synthetic biology. Free information can be found in the registry regarding parts, devices and modules all inputted by various teams worldwide.

Eukaryotic synthetic biology is still in its infancy. The large kingdom of metazoans includes all multicellular eukaryotes such as mammalians, arthropods and nematodes. No standard chassis (framework) exists for the animal kingdom which makes them far less popular then the famous E.coli. The protein modules derived from metazoans (like Drosophila or C. elegans) are functional in yeasts also. Very few iGEM teams (or even labs outside iGEM) have chosen to toggle the animal chassis (two notable examples are team Heidelberg 2009 and team Slovenia 2006). The amount of available compatible parts is limited, which severely restricts the options of creating complex biological devices. Nearly no imagination is required for designing tools, since their analogues already exist in the bacterial chassis. The possible use of such systems is unlimited. Field’s such as of environment, medicine, energy and research all gain to profit from the development of animal synthetic biology.

Systems requiring gene expression input in eukaryotic synthetic biology systems require a way to standardize gene expression, a complicated task. The way from gene to protein contains many steps of possible error: transcription factor binding, promoter strength, recruitment of auxiliary proteins, nuclear RNA synthesis and many more steps finally leading to translation, folding, cleaving and delivery (but hey, you have to start somewhere).

Our team was interested at designing eukaryotic synthetic biology tools related to PoPs. PoPs (polymerase per second), the flying Dutchman of synthetic biology, is a number which represents the rate (base pair per second) at which RNA polymerase crosses past a given DNA position. Currently, no in vivo technique for measuring PoPS directly exists; it can be estimated indirectly by measuring other parameters (eg protein expression or enzyme activity). Nevertheless it is still a useful abstraction for thinking about transcription-based logic devices and it allows the engineer to define devices. Our aim, was not only to infer PoPs but to devise a way to titrate it remotely.


New Tools for Synthetic Biology: Nuclear Receptors

Nuclear receptors, best viewed as transcription factors which can be activated by extracellular cues, are unique in their ability to allow direct remote PoPs titration (both activation and repression). These receptor classes bears high homology to each other throughout the animal kingdom and are modular into distinct domains. All of these features attracted our attention to find a way to incorporate these tools in the parts registry, and characterize them in standardized methods.

Many nuclear receptors, are among the primary targets of drug discovery because of their diverse biological actions. Nuclear receptors bear high homology to each other and are modular into distinct domains: N-terminal regulatory domain, DNA-binding domain, a Hinge region, Ligand binding domain (LBD) and a C-terminal domain.The LBD is the segment of the receptor which changes its conformation upon lipophilic ligand binding; this also causes the exposure of a powerful transcriptional activation domain (which attracts the transcriptional machinery). This was our segment of interest since it links ligand binding with transcriptional activity.

Nuclear Receptor Structure resized.jpg

Our team has generated a library of ligand binding domains for the rational construction of synthetic titrateable transcription factors. In our model hybrid receptor, this LBD was fused to a Gal4 DNA binding domain. The sequence to which Gal4 binds is CGG-N11-CCG, where N can be any base. Although Gal4 is a yeast protein not normally present in other organisms it has been shown to work as a transcription factor in a variety of organisms such as Drosophila, and human cells, highlighting that the same mechanisms for gene expression have been conserved over the course of evolution.

The examination of these chimeric receptors was through a version of the two hybrid assay. For a more detailed description of our experimental system, please visit our "Minimals" page.



Results

First we had to generate expression vectors that can be used in mammalian expression systems. The cloning work of Team Debrecen-Hungary resulted 20 basic parts in pSB1C3 and 13 composite parts in pSB1C3 or pSB1A3. All of them have been tested by restriction enzyme analysis and by sequencing. Furthermore, some basic and fused parts have been ligated into pCDNA3.1 containing a specific adaptor by which RFC-25 compatible parts can be inserted into this expression vector. pCDNA3.1 results constitutive expression of the inserted part in the cells so the investigated part can be tested at functional level. The other expression vector is a fully SB (Synthetic Biology) compatible mammalian expression vector generated from pSB1A3. We inserted into the pSB1A3 the TRE (tetracycline response element) a strong CMV (cytomegalo virus) promoter and a polyA element that is a terminator of transcription in mammalian cells. These four elements are available as individual parts in the parts registry and can be used in combination with other parts too.

Basic Parts

18 basic parts have been inserted into pSB1C3 which contain 3 DBDs, 1 hinge, 11 LBDs, 2 regulators and 1 apoptosis protein.

Composite Parts

13 composite parts have been created, ten of them consist of two basic parts, one of them has been built up from three basic parts, and an expression vector from standard biobrick parts has been created by using four basic parts. The backbone has been opened with AgeI and PstI restriction enzymes in order to ligate the part cut out with NgoMIV and PstI. The previous restriction digests have been repeated so each part could be inserted after the previous one.

Gal4-human LBD fusions

Two human nuclear hormone receptor LBDs (Pregnane X Receptor LBD, Estrogen Receptor LBD) have been inserted into pSB1C3 after Gal4 was ligated into the backbone. The Gal4 (438 bp) is a modular protein consisting of a DNA-binding domain and an activation domain which can be used in Two-Hybrid system in order to identify interactions between two proteins or a protein with DNA. The length of PXR LBD is 732 bp while the ER LBD is 828 bp long, so the fusion leads to 1170 bp and 1266 bp long composite inserts.

pSB1C3-Gal4-PXR
pSB1C3-Gal4-ER

Both of them have been transferred into pCDNA3.1 to express them in certain cell lines.

pCDNA-Gal4-PXR
pCDNA-Gal4ER

Gal4-Ecdysone receptor fusion

The LBD of Ecdysone Receptor (639 bp) which can be found in arthropodes has been inserted after the Gal4 both in the pSB1C3 and pCDNA3.1 resulting an 1077 bp long insert in the vectors.

pSB1C3-Gal4-EcR
pCDNA-Gal4-EcR

Gal4-C. elegans LBD fusions

Five nuclear hormone receptor LBDs of C. elegans (NHR8, NHR23, NHR31, NHR80, DAF12) have been inserted after Gal4 in pSB1C3, resulting inserts with the lenght between 944 bp and 977 bp. All of the Gal4-C.elegans LBD constructs (e.g. Gal4-NHR8) except Gal4-NHR80 composite part have been fused into pCDNA3.1 expression vector to test them as a lipid sensor.

pSB1C3-Gal4-NHR
pCDNA-Gal4-NHR8

Estrogen Receptor from basic parts

Estrogen receptor DBD (318 bp) and LBD (828 bp) have been inserted together into pSB1C3. The two main domains of ER are linked together by the hinge region of Vitamin D Receptor (357 bp) resulting a 1503 bp long insert in the backbone.

pSB1C3-ER_DBD-VDRh-ER_LBD

Creating expression vector from pSB1A3

Three basic parts from pSB1C3 have been ligated into pSB1A3 consecutively by using chloramphenicol and ampicillin assembly in order to create an expression vector from the ampicillin resistance carrying backbone.

pSB1A3-TRE-Gal4-PXR
pSB1A3-TRE-Gal4-EcR

The first step was to insert 321 bp long TRE-CMV (Tetracyclin Response Element- Minimal Cytomegalovirus promoter) into pSB1A3 which has the length of 2157 bp. Then Gal4-PXR LBD (1170 bp) and Gal4-Ecr LBD (1077 bp) fusions were inserted after the TRE- CMV, before PolyA tail (191 bp) was ligated in the end.

pSB1A3-TRE-Gal4-PXR-PolyA
pSB1A3-TRE-Gal4-EcR-PolyA

As the negative control of the expression vector built up from standard biobrick parts TRE- CMV and PolyA tail were ligated together into pSB1C3 and pSB1A3.

pSB1A3-TRE-PolyA

The functionality of these vectors was assesed by Gal4 Western Blot.

Transients cotransfection assay /two-hybrid system/

We moved the composite parts generated in pSB1C3 into the expression vectors and transfected them into COS- 1 cells. The new “hybrid” receptors were designed to enhance the gene expression of a luciferase enzyme through a GAL4 sensitive promoter (which was also transfected). The luciferase activity was assessed photometrically for several ligand concentrations and normalized to a constitutively expressed beta-gal activity. The final result was plotted on a dose response curve. The EC50 was then extracted from the curve.


Request for comment suggestion : ??????




Plans, Possibilities

The remotely activated transcription factor concept can be used to construct highly complex synthetic biological systems, for us it was a very appealing concept. Physicians may use fruit fly hormones in humans to titrate specific genes in gene therapy patient in selected tissue, such as dopamine receptor genes in schizophrenia. Worm species that can synthesize a different color reaction based on the amount of environmental pollutants in the soil they live. Scientists may induce stem cell pluripotency by titrating the exact amount of oncogenes needed for a fibroblast to turn into an embryo.

The defenite next step would be to add DBD's to the registry, or more exact a way for users to synthesize a DNA binding domain according to their sequance of interest. DNA binding domains are themselves modular from sybdomains as: helix loop helix, leucine zippers, helix turn helix and zinc fingers (the most popular subdomains). Once our team assembles a zinc finger toolkit with carefull construction instructions, a user could in vitro or in silico assemble and predict where in the genome his artificial transcription factor/ nuclear receptor will act on gene expression. In the future this will allow full freedom of harnesing the potency of artificial titratable transcription factors.

In our system we would like to induce apoptosis by increasing the amount of proapoptotic proteins such as BAX by producing an expression vector containing TRE-minimal CMV promoter, BAX or PUMA and polyA tail. The pro-apoptotic proteins are able to express only in a controlled form using the Tetracyclin-controlled transcriptional activation system. The overexpression of these proteins can lead to Mitochondrial Outer Membrane Permeabilisation (MOMP) leading Cytochorome c release which is a point of no return in the mitochondrial pathway of Programmed Cell Death (PCD). The goal is to “switch off” the cells, which were genetically modified by us, after they “finished their work” in the recent local environment combining the components of the tetracycline-inducible system in self-contained retroviral and plasmid vectors.

Furthermore human, arthropode or C. elegans nuclear hormone receptor composite constructs can be expressed in an inducible form using Tetracyclin-controlled transcriptional activation system rather than using a vector which ensures constitutive expression of the parts. In our system Tetracycline Response Element (TRE) is recognized and bound by the Tetracycline repressor (TetR) protein. The TRE consists of 7 repeats separated by spacer sequences and placed upstream of CMV minimal promoter that has basal expession in the abscence of bound TetR. Tetracycline derivatives (e.g. doxycycline) bind TetR and render it incapable of binding to TRE, thereby forcing the expression of target genes.

Contibution to project by team members

  • Students (in alphabetical order)
    • Timea Beregi
    • Erika Berényi
    • Shun Chieh Liu
    • Lior Malka
    • Daniel Markovits
    • Katalin Nagy
    • Lilla Ozgyin
    • Katalin Sandor
  • Student Team Coordinators (in alphabetical order)
    • Bence Daniel
    • Endre Kristof
    • Yakir Guri
    • Ophir Keret
  • Team Instructors (in alphabetical order)
    • Balint L. Balint
    • Peter Brazda
    • Mate Demeny
    • Gabor Zahuczky